Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-03-13Clinical Trial Update: Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients [Phase 1]
This is a Phase I/II feasibility trial evaluating Brentuximab Vedotin with second-line salvage DHAP chemotherapy in patients with refractory…
-
CLINICAL_TRIALS research · 2017-12-06Clinical Trial Update: Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) [Phase 1, Phase 2]
Phase 1/2 study investigating Antiminor Histocompatibility Complex (MiHA) T cells in patients with relapsed hematologic malignancies after m…
-
CLINICAL_TRIALS research · 2017-11-20Clinical Trial Update: Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
This clinical trial update describes a consent process change allowing collection of additional tissue during diagnostic biopsy in lymphoma …
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Low Dose Plerixafor Plus G-CSF in Mobilizing Stem Cells for Autologous Peripheral Blood Transplantation [Phase 2]
A Phase 2 trial is evaluating low-dose plerixafor plus G-CSF to mobilize stem cells for autologous peripheral blood transplantation in lymph…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating PD-1 knockout EBV-specific cytotoxic T lymphocytes for advanced EBV-associated malignancies, includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation [NA]
Pilot study evaluating whether hyperbaric oxygen therapy can improve outcomes during autologous peripheral blood stem cell transplantation i…
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) [Phase 2]
A Phase 2 multi-centre trial evaluating MBVD in elderly and/or cardiopathic patients with Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma
This clinical trial update examines how social inequalities affect participation and daily activity in children and adolescents with Hodgkin…
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Treatment for Classical Hodgkin Lymphoma in Children and Adolescents [NA]
This entry indicates an ongoing clinical trial evaluating treatment for classical Hodgkin lymphoma in children and adolescents, currently re…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial investigating thiotepa-based conditioning for allogeneic stem-cell transplantation in lymphoid malignancies, includin…
-
CLINICAL_TRIALS research · 2016-03-30Clinical Trial Update: Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 3]
This is a Phase 3 randomized trial comparing G-CSF alone versus intermediate-dose Ara-C plus G-CSF mobilization in patients with Hodgkin lym…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CD30-directed CAR-T therapy (CART30) for relapsed/refractory CD30-positive lymphomas is currently recr…
-
CLINICAL_TRIALS research · 2015-10-19Clinical Trial Update: Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) [Phase 2]
Phase 2 clinical trial evaluating PET-guided (PET-adapted) chemotherapy strategies in patients with advanced Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2015-10-19Clinical Trial Update: Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions
A clinical trial update discusses using dual-point PET scanning to evaluate imaging in early-stage Hodgkin lymphoma with bulky lesions.
-
CLINICAL_TRIALS research · 2015-10-19Clinical Trial Update: Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma
A clinical trial investigating early chemotherapy intensification in patients with interim-PET positive Hodgkin lymphoma; the current status…
-
CLINICAL_TRIALS research · 2015-10-15Clinical Trial Update: Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
A completed genetic study in patients receiving treatment for Hodgkin lymphoma or pediatric brain tumors is reported in this Duke University…
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [EARLY_Phase 1]
Early-phase 1 trial evaluating dose monitoring of busulfan in conditioning regimens with combination chemotherapy for Hodgkin lymphoma or No…
-
CLINICAL_TRIALS research · 2015-02-04Clinical Trial Update: Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes [NA]
This clinical trial update describes evaluating interim PET scans to guide therapy modification in advanced Hodgkin lymphoma in an effort to…
-
CLINICAL_TRIALS research · 2014-10-27Clinical Trial Update: Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Brentuximab Vedotin followed by ABVD in patients with previously untreated Hodgkin lymphoma.
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 clinical trial update assessing BeGEV (Bendamustine, Gemcitabine, and Vinorelbine) as induction therapy for relapsed/refractory Hodg…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma [Phase 1]
Clinical trial update describing a Phase 1 study of the PIGEV combination before autologous stem cell transplant in Hodgkin lymphoma. The cu…
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating valproic acid in patients with previously treated non-Hodgkin lymphoma, Hodgkin lymphoma, or chro…
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease [Phase 3]
Phase 3 trial comparing combination chemotherapy plus radiation therapy versus radiation therapy alone in early-stage Hodgkin lymphoma.